EFFECTS OF TAXOTERE ON MURINE AND HUMAN TUMOR-CELL LINES

被引:140
作者
RIOU, JF
NAUDIN, A
LAVELLE, F
机构
[1] Rhône-Poulenc Rorer, Unité de Cancérologie, Centre de Recherche de Vitry-Alfortville
关键词
D O I
10.1016/S0006-291X(05)81474-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Taxotere (RP 56976, NSC 628503), an analog of taxol, is an inhibitor of depolymerisation of microtubules and is currently in Phase I clinical trials. Comparisons of the cytotoxicities of Taxotere and taxol have been studied on several murine (P388, SVras) and human cell lines (Calc18, HCT116, T24, N417, KB). Taxotere was found more potent than taxol (1.3-12 fold), a result which could be explained by its higher affinity than taxol for microtubules. In agreement with its postulated mechanism of action, Taxotere is more cytotoxic on proliferating than on non proliferating N417 cells and does not inhibit cellular DNA, RNA and protein synthesis. Taxotere gives partial cross resistance on P-glycoprotein resistant P388/DOX cell line, in contrast to taxol which gives a complete cross resistance. On the other hand, no cross resistances were observed on Calc18/AM and P388/CPT5 cell lines, bearing modified activities of topoisomerase II and topoisomerase I, respectively. These results underline the higher cytotoxic activity of Taxotere compared to taxol, and the lack of cross resistance of that class of agent with the topoisomerase I and II-related multidrug resistance phenotypes. © 1992 Academic Press, Inc.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 22 条
  • [1] UNKNOTTING THE COMPLEXITIES OF MULTIDRUG RESISTANCE - THE INVOLVEMENT OF DNA TOPOISOMERASES IN DRUG-ACTION AND RESISTANCE
    BECK, WT
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (22): : 1683 - 1685
  • [2] BISSERY MC, 1991, CANCER RES, V51, P4845
  • [3] BISSERY MC, 1991, P AM ASSOC CANC RES, V32, P2386
  • [4] BRATTAIN MG, 1981, CANCER RES, V41, P1751
  • [5] P-GLYCOPROTEIN GENE AMPLIFICATION AND EXPRESSION IN MULTIDRUG-RESISTANT MURINE P388 AND B-16 CELL-LINES
    CAPRANICO, G
    DEISABELLA, P
    CASTELLI, C
    SUPINO, R
    PARMIANI, G
    ZUNINO, F
    [J]. BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 682 - 685
  • [6] CARNEY DN, 1985, CANCER RES, V45, P2913
  • [7] DEISABELLA P, 1990, MOL PHARMACOL, V37, P11
  • [8] A HIGHLY EFFICIENT, PRACTICAL APPROACH TO NATURAL TAXOL
    DENIS, JN
    GREENE, AE
    GUENARD, D
    GUERITTEVOEGELEIN, F
    MANGATAL, L
    POTIER, P
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (17) : 5917 - 5919
  • [9] DREWINKO B, 1981, CANCER RES, V41, P2328
  • [10] GUERITTEVOEGELE.F, 1991, P AM ASSOC CANC RES, V34, P992